Watson wins U.S. OK for generic Nicorette mint gum (Reuters)

Reuters – U.S. health regulators approved Watson Pharmaceuticals Inc’s generic version of GlaxoSmithKline Plc’s Nicorette mint gum, an over-the-counter product to help smokers quit, Watson said on Wednesday.

Leave a Reply